Novo Nordisk remains confident in the benefit-risk profile of our GLP-1 medicines, when used consistent with their indications and product labeling. Drug companies are making big bucks from GLP-1 medications
It has been applied in various therapeutic contexts, particularly in cancer treatments, due to its ability to sensitize tumor cells to chemotherapy by inhibiting GSTP1, which is involved in drug resistance
$24.99/month or $59.99/quarter From picking your plan to getting care, here's how easy it is to get started
Patient monitoring should include: Baseline lipid panel, hemoglobin A1c, and liver function tests Blood pressure monitoring (GLP-1 agents typically reduce systolic BP by 3-5 mmHg) [10] Assessment for gastrointestinal adverse effects during dose titration Evaluation for contraindications (personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2) [1] [3] Monitoring for gallbladder disease (increased risk with rapid weight loss) In patients with diabetes and retinopathy, monitoring for worsening eye symptoms, particularly with rapid glycemic improvement Renal function assessment, especially if severe gastrointestinal symptoms cause dehydration Patients should seek immediate medical attention for severe abdominal pain, which may indicate pancreatitisa rare but serious adverse effect

These covariates included patient characteristics as well as tumor characteristics known to have associations with BMI, including stage at diagnosis, histology, and breast cancer subtype